High Tower Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

High Tower Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $4,975 - $20,612	-17,769 Reduced 31.01%	39,539 $13,000
Q1 2024 May 06, 2024	SELL	$1.06 - $1.67 $19,072 - $30,048	-17,993 Reduced 23.89%	57,308 $66,000
Q4 2023 Feb 12, 2024	BUY	$1.26 - $1.79 $14,306 - $20,323	11,354 Added 17.76%	75,301 $127,000
Q3 2023 Nov 08, 2023	BUY	$1.61 - $2.54 $28,342 - $44,714	17,604 Added 37.99%	63,947 $115,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $10,017 - $17,134	-8,787 Reduced 15.94%	46,343 $86,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.19 $9,427 - $17,204	7,856 Added 16.62%	55,130 $73,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $3,773 - $8,148	2,315 Added 5.15%	47,274 $79,000
Q3 2022 Nov 09, 2022	SELL	$0.73 - $3.74 $8,285 - $42,449	-11,350 Reduced 20.16%	44,959 $141,000
Q2 2022 Aug 10, 2022	BUY	$2.2 - $4.2 $2,820 - $5,384	1,282 Added 2.33%	56,309 $133,000
Q1 2022 May 12, 2022	BUY	$2.83 - $8.69 $67,331 - $206,752	23,792 Added 76.17%	55,027 $222,000
Q4 2021 Feb 10, 2022	SELL	$8.31 - $14.92 $11,260 - $20,216	-1,355 Reduced 4.16%	31,235 $260,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $298,198 - $432,795	32,590 New	32,590 $377,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.